Sign in Subscribe

Guardant Health Ordered to Pay Over $245 Million in DNA Sequencing Patent Dispute

Court orders Guardant Health to pay over $245.2M for willfully infringing TwinStrand’s DNA sequencing patents. Ongoing 6% royalties apply; Guardant will appeal.

Guardant Health Ordered to Pay Over $245 Million in DNA Sequencing Patent Dispute
Credit: Guardant Health
Already have an account? Sign in.